Sign up to the UK Share Picking Game

Immupharma (IMM) Health Care Sector


Members only

To view this content and much more please Sign Up


Latest Quote Price

Price Change (%)


NOTE: This is based on 7 open tips for this company


Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only


Immupharma Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

Latest Immupharma Tips

Type Tipster SectorScore Start date Performance
Northland Capital 2018-04-17 16:35:00 17/04/2018
Paul Summers 2018-03-01 09:50:00 01/03/2018
FinnCap 2017-12-21 11:30:00 21/12/2017
FinnCap 2017-12-12 08:00:00 12/12/2017
Harvey Jones 2017-10-09 15:30:00 09/10/2017

Immupharma Data Charts

Premium Charts


Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :

Immupharma Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

Latest Immupharma Tips

Type Tipster SectorScore Start date Performance
Northland Capital 2018-04-17 16:35:00 17/04/2018
Paul Summers 2018-03-01 09:50:00 01/03/2018
FinnCap 2017-12-21 11:30:00 21/12/2017
FinnCap 2017-12-12 08:00:00 12/12/2017
Harvey Jones 2017-10-09 15:30:00 09/10/2017